Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Profound Medical (PROF) Cost of Revenue (2024 - 2025)

Profound Medical (PROF) has 2 years of Cost of Revenue data on record, last reported at $2.0 million in Q4 2025.

  • For Q4 2025, Cost of Revenue rose 63.59% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $4.7 million, up 29.15%, while the annual FY2025 figure was $4.7 million, 29.15% up from the prior year.
  • Cost of Revenue reached $2.0 million in Q4 2025 per PROF's latest filing, up from $1.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $2.0 million in Q4 2025 and bottomed at $573000.0 in Q1 2024.